TrackTime, LLC v. Amazon.com Svcs. LLC, Appeal No. 2024-1102 (Fed. Cir. July 2, 2026) - In a lengthy, 26-page opinion, a panel of ...
On June 30, 2026, FINRA published “Recommendations Based on a Review of the Policies, Procedures, Processes, and Practices of FINRA’s ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...